UnitedHealth’s plan to defend its PBM: 5 things to know

(By Rylee Wilson for Becker’s Hospital Review)

Optum Rx will pass 100% of the rebates it negotiates for drugs onto its consumers by the end of 2028, UnitedHealth Group CEO Andrew Witty told investors.

On the company’s fourth-quarter earnings call on Jan. 16, Mr. Witty told investors most of the pharmaceutical benefit manager’s clients choose plans where they receive the full amount of rebates. A few choose other models. Continue reading here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.